Sir, I have a question on our cost and productivity effectiveness program. So the 3% to 6% savings that we are highlighting, would this be the gross savings or net savings, net of reinvestment, number one. And this will be on F Y'25 revenue base? If you can just clarify this particular thing.
Sure, sir. And the savings should materialize over what period of time frame?
Sir, sorry, stretching a bit more on India-UK. FTA, but can you just call out like what could be the benefit on the bulk scotch front on an annualized basis , once the UK. -- India-UK FTA comes into effect?
Okay. Sir, some of your smaller competitors have been quoting a higher number, so any -- more or less similar set of numbers. So is this a bit more conservative or this is what we expect?
Hi. Thanks for the opportunity. Sir, just a couple of questions. One on McDowell's X -series, almost a year since launch, but we haven't -- at least from our channel checks, we are not seeing much of action. Any specific thing over there on vodka, brandy, run, all 3 segment side? So, this is the first question. Second, on the UP market, while it is seen as a very large growth market, a lot of investments from our peer sets, both on the beer as well as on the IMFL side in those markets. But we seem to be lagging in that market. Any specific if you can share to drive the share over there?
Sure, sir. That was useful. Just one last question, a bookkeeping questi on to Pradeep. Pradeep, the INR37 crores impairment of interest on receivables, is this a onetime entry or this will be a recurring phenomenon every quarter, every year? How should we read it? And if you can deep dive more the context behind this particular revenue reversal?
So, there's a couple of questions , o ne is the AP policy change. If it happens , can you help understand, how will it benefit us as a Company and what is the salience of EP in our volumes and revenue?
Yes.
Sir, just a couple of questions. First , is our capex on the greenfield expansion of Sitapur complete? Or there will be some additional spend that will come up in H2 FY24 for Sitapur plant?
Okay. So, in this front, can you guide for our capex number for H2 FY24 and FY25?
So, one question. We went back to Supreme Court filing a curative p etition with respect to the differences or errors in the AGR liability. So, just want to understand what is the difference that we are envisaging? And why we are going back after almost a gap of 2.5 years since this amount was crystallized over the last Supreme Court judgment?
Sure, sir. This is very helpful and very clear. Just a small follow-up on this. Will there be any kind of hearings on the curative petition or the court will just review the filings and basis that they will unanimously decide on the curative petition, whether to give any kind of revision or not, this is one? And are there any timelines with respect to the curative petition outcome?
Sir, in Mumbai market, micro market, lot of the supply is coming up which is expected in this calendar year as well as in the next calendar year, and Mumbai is one of our key markets with a significant revenue contribution. So, what is giving us confidence of double digit ARR growth in this backdrop of increased room supply?